Virtus LifeSci Biotech Products ETF (BBP)

NYSE Arca: BBPExchange-traded fund from Virtus.

  • Expense ratio0.77%
  • Net assets$130.6M
  • Dividend yield0.00%
  • 1-year return+41.75%
  • Holdings65

BBP ETF price chart

BBP quote & trading statistics

BBP performance

Total return · as of October 17, 2026
  • YTD+32.10%
  • 1 year+41.75%
  • 3 years+28.96%/yr
  • 5 years+15.59%/yr
  • 10 years+12.57%/yr
1Y volatility
17.36%
3Y volatility
20.19%
3Y Sharpe ratio
1.13

Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.

BBP top 10 holdings

Virtus LifeSci Biotech Products ETF largest holdings by weight
#SymbolNameWeight
1MRNAModerna Inc5.77%
2IOVAIovance Biotherapeutics Inc4.44%
3VSTMVerastem Inc2.74%
4OMEROmeros Corporation2.46%
5HALOHalozyme Therapeutics Inc2.34%
6XERSXeris Pharmaceuticals Inc2.03%
7KNSAKiniksa Pharmaceuticals Ltd1.98%
8BGNEBeiGene Ltd1.90%
9RIGLRigel Pharmaceuticals Inc1.84%
10PGENPrecigen Inc1.83%

The top 10 holdings make up 27.3% of the fund (65 holdings in total). As of October 17, 2026.

BBP sector weights

Healthcare
100.0%

BBP region weights

North America
97.2%
Asia Emerging
1.7%
United Kingdom
1.4%
Europe Developed
1.3%

BBP asset allocation

U.S. stocks
92.9%
Non-U.S. stocks
4.6%
Cash
0.3%

BBP market-cap breakdown

Micro cap
36.8%
Small cap
31.9%
Mid cap
19.0%
Large cap
5.9%

About Virtus LifeSci Biotech Products ETF

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.

BBP ETF FAQ

What is the BBP expense ratio?

Virtus LifeSci Biotech Products ETF has a net expense ratio of 0.77%, or $77.00 a year for every $10,000 invested.

How much money is in BBP?

Virtus LifeSci Biotech Products ETF has about $130.6M in net assets.

What are the top holdings of BBP?

The largest positions in BBP are Moderna Inc (5.77%), Iovance Biotherapeutics Inc (4.44%), Verastem Inc (2.74%). The fund holds 65 securities in total.

How has BBP performed?

BBP returned +41.75% over the past year and +15.59% a year over the past five years, including reinvested distributions.

Does BBP pay dividends?

BBP has a dividend yield of 0.00% and pays distributions na.

When was BBP launched?

Virtus LifeSci Biotech Products ETF began trading on December 16, 2014.